EPPP Psychopharmacology Practice Exam 2026 – The Comprehensive Guide to Mastering Your Exam!

The choice of Strattera as the FDA-approved treatment for ADHD is not accurate in the context of this question, since Strattera (atomoxetine) is a non-stimulant medication that is also approved for ADHD but is not classified among the stimulants.

On the other hand, Concerta, Ritalin, and Dexedrine are all stimulant medications that are approved for treating Attention-Deficit/Hyperactivity Disorder (ADHD). Ritalin (methylphenidate) and Concerta (a long-acting formulation of methylphenidate) share the same active ingredient, while Dexedrine (dextroamphetamine) is an amphetamine-based stimulant.

In summary, when considering stimulant medications specifically approved for ADHD, Concerta, Ritalin, and Dexedrine are all valid options, while Strattera is categorized differently, being a selective norepinephrine reuptake inhibitor (NRI). Understanding the classification and mechanism of these medications is crucial when discussing ADHD treatment options.